Discontinuation report XIAFLEX
Report ID | 118623 |
Drug Identification Number | 02388316 |
Brand name | XIAFLEX |
Common or Proper name | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM |
Company Name | ENDO VENTURES LTD. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM |
Strength(s) | 0.9MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRALESIONAL INTRALESIONAL |
Packaging size | 1 Vial |
ATC code | M09AB |
ATC description | OTHER DRUGS FOR DISORD. OF THE MUSCULO-SKELET.SYST |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-06-15 |
Actual discontinuation date | 2020-06-15 |
Remaining supply date | 2020-06-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE, DUBLIN IRELAND D04 H9P8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-06-22 | French | Compare |
v1 | 2020-06-22 | English | Compare |
Showing 1 to 2 of 2